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Copyright © 2009 JCBN Summary The overexpression of murine double minute 2 (MDM2) is found in several human
tumors, and increased expression of MDM2 inactivates the apoptotic and cell cycle arrest
function of p53. Interleukin-16 (IL-16) is a pleiotrophic cytokine and the properties of IL-16
suggest that it involve in the pathophysiological process of chronic inflammatory diseases. In
this study, we investigated the expression of MDM2 in intestinal metaplasia and gastric cancer
as well as the effect of H. pylori infection and IL-16 on epithelial cell proliferation and MDM2
expression in gastric cells in vitro. The expression of MDM2 on gastric biopsies was studied
immunohistochemistry. AGS cells were incubated with a combination of IL-16 and
Helicobacter pylori (H. pylori). Gastric epithelial cell proliferation was studied by BrdU uptake
and the expressions of MDM2 were studied by ELISA. There was no significant difference on
the expression of MDM2 between with and without H. pylori infected chronic gastritis. In H.
pylori infected gastric mucosa; the MDM2 expression was higher on intestinal metaplasia and
gastric cancer than chronic gastritis. IL-16 administration was increased MDM2 expression
and cell proliferation on AGS cells, which was decreased by H. pylori infection. In conclusion,
the expression of MDM2 in long-term H. pylori infected gastric mucosa may indicate a risk for
carcinogenesis. IL-16 secretion in H. pylori infected mucosa is one of the factors for gastric
cancer. The expression of MDM2 on mucosa can be a mediator for gastric cancer.
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Introduction
The development of gastric carcinoma involves a multistep
process from chronic gastritis to atrophy, intestinal metaplasia
and dysplasia. It has been shown that atrophic gastritis and
intestinal metaplasia significantly increase the risk of gastric
carcinoma. The infection of Helicobacter pylori (H. pylori)
induced chronic gastritis is significantly more pronounced in
gastric carcinoma patients [1,  2].  H. pylori colonization
alters specific host physiology, such as gastrin secretion and
gastric epithelial cell cycle events. H. pylori colonization
also increases apoptosis and proliferation in human gastric
tissue [3–6]. H. pylori infection also induces infiltrations of
neutrophils, macrophages, dentric cells, as well as B and T
cells [7]. This infiltration of inflammatory cells is an
important factor for mucosal change from chronic gastritis
to intestinal metaplasia, and this infiltration is one of the
factors for gastric carcinogenesis.
Interleukin-16 (IL-16) was initially described as a T cell
chemoattractant. In vivo studies have more fully characterized
IL-16 as an immunomodulatory cytokine that contributes to
the regulatory process of CD4+ T cell recruitment and
activation at sites of inflammation in association with
asthma and several autoimmune diseases [8]. Although IL-
16 can be produced by a variety of cell types, the productionMDM2 Expression on Gastric Cancer
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and timing of release of bioactive IL-16 vary depending on
the cell origin. CD8+ T cells contain processed bioactive
IL-16 whose release can be triggered within 1–4 h by a
variety of stimuli, such as histamine and serotonin. In
contrast, CD4+ T cells constitutively generate pro-IL-16
protein that is processed and secreted as bioactive IL-16
approximately 12–24 h after stimulation [9]. Lunden et al.
reported that the increased numbers of CD4+ T cells in the
antrum of H. pylori infected gastric mucosa, but comparable
numbers of CD8+ T cells [7]. From these studies, the infiltra-
tion of inflammatory cells is important factor for gastric
mucosal injury and cell cycle, but the influence of IL-16
expression on gastric mucosa by long-term infection with
H. pylori, is not clear.
The p53 transcript factor functions as a tumor suppressor
by inducing the expression of genes that inhibit cell growth
and promote apoptosis [10]. The mdm2 gene encodes a 491
amino-acid protein that contains a binding domain for the
tumor suppressor of p53 [11]. Murine double minute 2
(MDM2) was shown to bind the tumor suppressor p53 and
inhibit p53-mediated transsactivation. The overexpression
of MDM2 was another mechanism by which the cell could
inactivate p53 in the process of transformation. The over-
expression of the MDM2 gene is frequent in many human
breast carcinomas, soft tissue sarcomas and other cancers,
suggesting that MDM2 overexpression may be one of the
common causes of oncogenesis [12].
In this study, we investigated the expression of MDM2 on
chronic gastritis, intestinal metaplasia and gastric cancer in
H. pylori infected mucosa. In vitro study, we also investi-
gated the effect of IL-16 administration and H. pylori infec-
tion on gastric epithelial cell proliferation and the expression
of MDM2 on AGS cells.
Materials and Methods
Gastric samples
Gastric biopsies were taken through endoscopy, and
classified into chronic gastritis, intestinal metaplasia and
gastric cancer by histological findings. H. pylori infection
was studied by taking 2 samples for culture, 2 samples for
rapid urea test and 2 samples for histological findings. H.
pylori infection was diagnosed if anyone of the 6 biopsies
tested positive.
Expressions of MDM2 protein on gastric biopsies
The biopsies from chronic gastritis without H. pylori
infection (n = 20), chronic gastritis with H. pylori infection
(n = 20), intestinal metaplasia with H. pylori infection
(n = 20) and gastric cancer with H. pylori infection (n =2 0 ) ,
were studied. The paraffin-embedded blocks were cut into
5 µm sections. Then they were mounted on slides and de-
waxed in xylene and sequentially dehydrated in 100%, 80%
and 70% ethanol. DNA in the specimens was degenerated
by 4 M HCl for 30 min, and the intrinsic peroxidase was
blocked with 0.3% hydrogen peroxide in methanol. Non-
specific binding was blocked with PBS containing 3%
skimmed milk (Wako, Tokyo, Japan) for 30 min. To enhance
immunostaining, sections were treated with an antigen
retrieval solution (10 mM citrate acid monohydrate, pH 6.0,
adjusted with 2 N NaOH) and heated 3 times in a microwave
oven at high power for 5 min. After the specimens were
incubated with anti-MDM2 mouse antibody (Santa Cruz,
CA) overnight at 4°C, they were washed with PBS, followed
by incubation with biotinylated secondary anti-mouse goat
antibody (Dako, Copenhagen, Denmark) diluted 20-fold for
1 h. After washing the tissues with PBS, sections were
incubated with avidin-biotin complex (ABC Elite: Vector
Laboratoried Inc. Burlingame, CA). Peroxides conjugates
were subsequently localized using diaminobenzidine tetra-
hydrochloride as a chromogen. Sections were counterstained
with Haematoxylin. Image Manager Software applied to a
light microscope was used for computer analysis of each
sample. The degree of immnopositive for MDM2 was
evaluated semi-quantitatively. In random fields from re-
presentative areas of gastric biopsies, the immunoreactive
cells were roughly assessed and expressed as a percentage.
Cell culture and regents
AGS cells were studied because they possess wild-type
p53 [13], in contrast to KATO-III cells and other cells that
have p53 deletions and/or rearrangement, which may affect
the response to signals that regulate cell cycle events [14].
AGS gastric epithelial cells were grown in F-12 Ham
medium (Gibco, Life-Technologies, Grand Island, NY)
supplemented with 10% fetal bovine serum (FBS, MP Bio-
medicals, Solon, OH) and antibiotic-antimycotic solution
(Sigma-Aldrich, St. Louis, MO). All cultures were main-
tained at 37°C in a humidified atmosphere of 95% air and
5% CO2. Cell culture experiments were carried out using
100 mm dishes (Nunc, Copenhagen, Denmark). H. pylori
(NCTC 11637) were grown on Skirrow agar (Oxoid,
Bashingstone, England) plate with 7% horse blood (Nippon
Biotest Lab. Tokyo, Japan) in an atmosphere of 10% CO2 at
37°C. Colonies were harvested, 105 and 106 cfu/ml of H.
pylori were resuspended in antibiotic-free F-12 without
FBS. Experiments were performed as 104 of AGS cells were
incubated with F-12 antibiotic-free media with 0.5% bovine
albumin (Trace Biosciences, NZ). Using 6-well poly-
propylene tissue culture plates, with the combination with/
without of 105, 106 cfu/ml of H. pylori and 10−10, 10−9 M of
recombinant human IL-16 (Pepro Tech, Inc, Rocky hill, NJ)
was added into AGS cells. Cells were harvested at 24 h
incubation.N. Nakajima et al.
J. Clin. Biochem. Nutr.
198
ELISA assay
AGS cells were grown on 6 well-plates (Nunc. Copen-
hagen, Denmark) and maintained in antibiotic-free F-12
medium without serum for 24 h prior to the experiments.
The combination of IL-16 and H. pylori were added in
serum-free medium, and co-cultured for 24 h. Cells were
labeled with Bromodeoxyuridine (BrdU: Sigma, St. Louis,
MO) for 1 h, and monolayers were washed 3 times with
PBS, lysed with 1 ml of lysis buffer (50 mM NaCl, 25 mM
Tris-HCl pH 8.0, 0.5% NP-40, 0.5% sodium deoxycholate
and 0.02% sodium azide). Cells were scraped, and trans-
ferred to eppendolf tubes. Particulate materials were
removed by centrifugation. Ten µg/ml of primary anti-BrdU
antibody (Dako, Copenhagen, Denmark) and anti-MDM2
antibody (Santa Cruz, CA) were dissolved with 0.01 M
phosphate buffer, 0.15 M NaCl, pH 7.2 into 10 µl, and
coated each well of 96 well-plates, and incubated plates
overnight at 4°C. After washing with Buffer B (0.01 M
Phosphate buffer, 0.50 M NaCl, 0.1% Tween 20, pH 7.2) 3
times, 100 µl of samples (6 times) were pipetted into wells,
and incubated for 2 h at room temperature. After the plates
were washed with Buffer B, the plates were then blocked for
30 min with 3% skim milk (Wako, Tokyo, Japan) in buffer
B. Secondary antibodies (Dako, Copenhagen, Denmark)
were incubated for 1 h. Plates were further incubated with
1:10000 of alkaline phosphatase conjugated streptoavidin
(Dako, Copenhagen, Denmark) for 1 h. Plates were washed
with 1:20 of AmpliQ washing buffer (Dako, Copenhagen,
Denmark) and the amplification reagents A and B were
added to all wells. Expressions were determined by a
spectrophotometer at 492 nm. The assay was followed by
ampliQ detection kit (K6245, Dako, Copenhagen, Denmark).
All data were expressed as % AGS cells only.
Statistical analysis
The Turney test was used to evaluate difference. A p value
of <0.05 was considered significant.
Results
The expression of MDM2 on gastric mucosa
In chronic gastritis, there was not a significant difference
on the expression of MDM2 protein between without H.
pylori and with the infection (chronic gastritis without H.
pylori infection vs. chronic gastritis with H. pylori infection:
3.60 ± 1.52 vs. 4.77 ± 1.92,  p = 0.31). But in H. pylori
infected gastric mucosa, the expression of MDM2 protein
was increased in intestinal metaplasia and gastric cancer
(chronic gastritis: 4.77 ± 1.92, intestinal metaplasia:
7.12 ± 2.16 p<0.001, gastric cancer: 7.76 ± 4.31, p<0.000)
(Fig. 1, 2).
Fig. 1. The expression of MDM2 on gastric mucosa by ABC staining. A. Chronic gastritis, B. Intestinal metaplasia, C. Gastric cancer
MDM2 was stained by DAB as brown area.
Fig. 2. The Expression of MDM2 on H. pylori infected gastric
mucosa in chronic gastritis (CG), intestinal metaplasia
(IM) and gastric cancer (GC). There was no significant
difference on CG between with and without H. pylori
infection. But in H. pylori infected mucosa, the expres-
sion of MDM2 increased in IM and GC more than CG.
(p<0.05)MDM2 Expression on Gastric Cancer
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The effect of H. pylori infection on gastric epithelial cell
proliferation
The in vitro study showed that the administration of 10−10,
10−9 M of IL-16 did not influence the BrdU uptake on AGS
cells. (AGS only 100 ± 21.97%, 10−10 M IL-16 administra-
tion on AGS cells: 95.85 ± 23.90%, 10−9 M IL-16: 102.54 ±
25.77%). But the 105 cfu/ml of H. pylori incubation decreased
BrdU uptake on AGS cells (AGS only: 100 ± 21.97% vs.
105 cfu/ml of H. pylori: 85.19 ± 13.57%,  p<0.001), 106
cfu/ml of H. pylori infection did not decrease the BrdU
uptake on AGS cells (106 cfu/ml of H. pylori: 105.78 ±
22.48%). Further 10−10, and 10−9 M of IL-16 administration
increased BrdU uptake on AGS cells which was decreased
by 105 cfu/ml of H. pylori infection (105 cfu/ml H. pylori:
85.19 ± 13.57% vs. 105 cfu/ml  H.pylori +1 0 −10 M IL-16:
97.82 ± 15.24%, 105 cfu/ml  H.pylori +1 0 −9 M IL-16:
102.80 ± 14.67%, p<0.001). Also the administration of IL-16
increased BrdU uptake on AGS cells with 106 cfu/ml of
H. pylori: (106 cfu/ml  H. pylori: 105.78 ± 22.48% vs.
106 cfu/ml  H. pylori +1 0 −10 M IL-16: 143.36 ± 22.65%,
106 cfu/ml  H. pylori +1 0 −9 M IL-16: 120.38 ± 12.62%,
p<0.001) (Fig. 3).
The expression of MDM2 protein levels on AGS cells
There was not a significant difference on MDM2 protein
levels of AGS cells between with and without 106, 105 cfu/ml
of  H. pylori infection (AGS cells only: 100 ± 15.83%,
105 cfu/ml H. pylori: 98.33 ± 22.68%, 106 cfu/ml H. pylori:
104.65 ± 11.22%). Also administration of 10−10, 10−9 M of
IL-16 did not have an influence on MDM2 protein levels on
AGS cells (AGS cells only: 100 ± 15.83%, 10−10 M IL-16:
86.13 ± 13.38%, 10−9 M IL-16: 92.28 ± 9.64%). But on
106 cfu/ml of H. pylori incubation, the further administration
of 10−10 and 10−9 M of IL-16 increased MDM2 protein levels
on AGS cells infected with 106 cfu/ml of H. pylori (106
cfu/ml  H. pylori: 104.65 ± 11.22%, 10−10 M IL-16 + H.
pylori: 111.75 ± 12.30%, 10−9 M IL-16 + H. pylori: 125.26 ±
11.26%, p<0.05) (Fig. 4).
Discussion
Infection with H. pylori is a causality of chronic gastritis,
gastroduodenal ulceration, and gastric cancer. Intestinal-
type gastric carcinogenesis occurs at a later age and
progresses through well-defined histological steps initiated
by the transition from normal mucosa to chronic superficial
gastritis, which then leads to atrophic gastritis and intestinal
metaplasia and finally to dysplasia and adenocarcinona [15].
Correa reported that populations at high risk of developing
gastric cancer had a higher prevalence of atrophic gastritis
than populations at low risk of developing gastric cancer
[16]. Gastric epithelial mucosal integrity is controlled by
the balance of cell loss and renewal. But epithelial cell
hyperproliferation is a factor for gastric carcinogenesis. H.
pylori infection increased epithelial cell proliferation in
gastric mucosa, and for stimulated gastric cell proliferation
by  H. pylori, the infiltration with inflammatory cells is
important factor.
Fig. 3. The effect of IL-16 and H. pylori infection on BrdU up-
take in AGS cells. The infection of H. pylori decreased
BrdU uptake on AGS cells. But further administration of
IL-16 increased BrdU uptake on AGS cells which had
been decreased by H. pylori infection.
Fig. 4. The effect of IL-16 and H. pylori infection on MDM2
expression in AGS cells. The infection of H. pylori
decreased MDM2 expression on AGS cells, but further
administration of IL-16 increased MDM2 expression on
AGS cells which had been decreased by H. pylori
infection.N. Nakajima et al.
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The human homologue of the mdm2 gene is frequently
overexpressed in many human cancers, suggesting that
MDM2 overexpression may be one of the common causes of
oncogenesis [12,  17]. Amplification of the mdm2 gene
enhances tumorigeneic potential of murine cells. Although
human cancer cells frequently overexpress MDM2, and
experimental evidences suggest that in normal cells, MDM2
overexpression causes G1 arrest, suggesting that MDM2
overexpression requires genetic alterations. The bio-
chemical activities of MDM2 in cancer cells have been
studied intensely because of its association with the tumor
suppressor p53 and its implication in human cancer. Cancer
cells that overexpress MDM2 may evade these checkpoint
regulatory pathways by selecting mutated cells [18].
In this study, we demonstrated that on H. pylori infected
mucosa, the expression of MDM2 was increased in intestinal
metaplasia and gastric cancer. But in chronic gastritis, there
was no significant difference on the MDM2 expression
between with and without H. pylori infection. These results
indicate that the expression of MDM2 is the trigger for the
stimulation and occurrence of gastric cancer, but H. pylori
infection only did not influence MDM2 expression. Kodama
et al. reported that in chronic gastritis, H. pylori infection
increased MDM2 protein levels more than non-infected
tissues [19]. The difference between their study and ours
may be the method of diagnosis for chronic gastritis. They
diagnosed chronic gastritis endoscopically, but in this study,
we diagnosed chronic gastritis by histological findings. In
our study, there was not a significant difference on MDM2
protein levels between with and without H. pylori infected
chronic gastritis, but the expression of MDM2 seemed to
increase. Previous studies demonstrated that the expression
of MDM2 increased in gastric cancer [20, 21]. From our
study, the expression of MDM2 protein was increased in
not only gastric cancer, but also in intestinal metaplasia
than chronic gastritis. The histological change of intestinal
metaplasia is important for the change to gastric cancer, and
the stimulation of MDM2 protein may be one of the factors
for the transition to gastric cancer.
To know the mechanisms for the different expression of
MDM2, we studied the expression of MDM2 and gastric
epithelial cell proliferation on the H. pylori infected cells
in vitro. In this study, we noticed the effect of IL-16 on
H. pylori infected gastric epithelial cells. Keates et al.
demonstrated that IL-16 protein levels were increased in
Crohn’s diseases, and anti-IL-16 antibody reduced TNBS-
induces injury [22]. IL-16 was originally isolated as lympho-
cyte chemoattractant factor, and IL-16 is a proinflammatory
cytokine that induces migration of CD4+ T lymphocytes as
well as activated CD4-bearing monocytes/macrophages and
eosinophils. IL-16 is produced predominately by activated
CD8+ T lymphocytes and to a lesser extent by CD4+ T
lymphocytes and eosinophils [23]. In humans, H. pylori
infection results in active chronic gastritis with continuous
infiltration of neutrophils, B cells and T cells. Lundgren
et al. reported increased numbers of CD4+ T cells in the
antrum of H. pylori-positive individuals [7]. Stimulated
infiltration of these inflammatory cells by H. pylori infection
is known as an important factor for gastric carcinogenesis,
and the effect of IL-16 may be one of the important factors
for chronic inflammatory diseases including chronic gastritis
by long-term infection with H. pylori.
In this study, we demonstrated that H. pylori incubation
decreased BrdU uptake on AGS cells, but further admin-
istration of IL-16 increased cell proliferation, which was
decreased by H. pylori infection. On the other hand, Joe
et al. demonstrated H. pylori increased tritiated thymidine
incorporation on KATO III cells [24]. The reasons of the
differentiation between these studies were the difference of
cell lines and concentration of H. pylori administration. In
most  H. pylori infected patients, the bacteria infected in
childhood and persisted into adulthood. This long-term
infection with H. pylori causes stimulation of inflammatory
cells including monocytes, neutrophils. Especially, the IL-8
is one of the important cytokines for H. pylori infected gastric
mucosa for the occurrence of gastrointestinal ulceration
and gastric cancer. We investigated the expression of IL-16
in gastric mucosa, and there was no significant difference in
the expression of IL-16 on gastric mucosa (data not shown).
But the administration of IL-16 increased BrdU uptake on
AGS cells which was decreased by H. pylori infection. In
vivo studies, we reported that H. pylori infection increased
cell proliferation on mice gastric mucosa [25, 26]. One of the
reasons for the difference between our in vivo and in vitro
study was the presence of inflammatory cell infiltration.
In gastric mucosa, infiltration of inflammatory cells and
expression of cytokines by H. pylori infection, stimulate cell
proliferation on gastric mucosa, and the proliferation is
increased by not only H. pylori infection directly. The
expression of IL-16 is one of the important factors for
stimulation of cell growth in H. pylori infected gastric
mucosa. One of the reasons for stimulation of cell growth
is, stimulation of oxidative stress by H. pylori infection.
Inflammation provides several sources of oxidants including
leukocytes, cytokines. The infiltration of this reactive oxygen
damaged gastric mucosa, and continual damage by long-term
infection of H. pylori leads to proteome changes related to
cell proliferation and carcinogenesis.
In our study, the expression of MDM2 protein was
decreased by H. pylori infection, but further administration
of IL-16 increased MDM2 protein which had been decreased
by H. pylori. From these results, H. pylori infection only is
not a trigger for the expression of MDM2, but infiltration of
inflammatory cells or the expressions of cytokines including
IL-16 are important factors for the expression of MDM2.
Ohmiya  et al. reported that MDM2 SNP309, a single-MDM2 Expression on Gastric Cancer
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mucleotide polymorphism in the MDM2 promoter can
impact tumorgenesis especially in the atrophic gastritis.
SNP309 elevated the risk for carcinoma in the stomach after
establishment of severe atrophic gastritis [27]. The presence
of SNP309 in the MDM2 gene leads to higher expression of
MDM2 protein. From their study, SNP309 can impact
tumorigenesis especially in atrophic gastritis. And also
SNP309 elevated the risk of carcinoma in the stomach after
establishment of atrophic gastritis. The expression of
MDM2 and SNP309 can be markers for gastric cancer in
atrophic gastritis, but severe inflammatory changes in
gastric mucosa are necessary for these expressions.
We conclude, the expression of MDM2 on gastric mucosa
may be one of the factors for gastric carcinogenesis by
long-term H. pylori infection, because MDM2 expresses on
gastric mucosa in the early phase of gastric cancer. Also,
the infiltration of IL-16 by H. pylori infection is a factor
for stimulation of MDM2 expression on H. pylori infected
gastric mucosa. The expression of IL-16 on H. pylori
infected gastric mucosa can be a trigger for stimulation of
epithelial cell proliferation on H. pylori infected gastric
mucosa.
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